Although, the standard model of care works well
for acute diseases, trauma, infection, and emergencies, sadly, it fails miserably in the care of the chronic diseases that affect so many of us.
Western medicine is ideal
for acute disease diagnostics and surgery.
While pharmaceuticals are better
for acute disease and surgery, acupuncture helps chronic conditions.
The tests include both genetic disease indicators, and
for acute disease such as brucellosis
Not exact matches
As a result, the Centers
for Disease Control and Prevention recommends using opioids sparingly
for severe,
acute pain, and only under special circumstances
for chronic pain.
In March, the U.S. Food and Drug Administration (FDA) approved BLINCYTO
for the treatment of adults and children with B - cell precursor
acute lymphoblastic leukemia in first or second complete remission with minimal residual
disease (MRD) greater than or equal to 0.1 percent.
CalciMedica is a privately - held, clinical stage biopharmaceutical company focused on CRAC channel drug discovery and development
for the treatment of
acute and chronic inflammatory
diseases.
The Xarelto partnership is seeking additional approved uses, with trials underway in patients with
acute coronary syndrome, and
for reduction of major adverse cardiovascular events in patients with heart failure or peripheral artery
disease.
Breast milk is a critical source of energy and nutrients during illness and reduces mortality among children who are malnourished.3 It reduces the risk of a number of
acute and chronic
diseases in early childhood and has long - term benefits
for cardio - vascular health.4 In the context of HIV, early cessation of breastfeeding after six months is associated with increased serious morbidity, growth faltering, and increased mortality.5
That's why parents choose the Division of Pediatric Pulmonology and Allergy at Floating Hospital
for Children
for the management of respiratory
diseases, allergic disorders and other
acute and chronic conditions in babies, kids and teens.
The Pediatric Nephrology Division at Floating Hospital in Boston provides expert
acute & chronic kidney
disease diagnosis and treatment
for children.
Epidemiologic research shows that human milk and breastfeeding of infants provide advantages with regard to general health, growth, and development, while significantly decreasing risk
for a large number of
acute and chronic
diseases.
Breastfeeding and hence relactation are important
for two reasons: Infant health: research shows that breastfed babies are less likely to suffer from
acute respiratory infections, diarrhoeal
diseases, and malnutrition.
The Division of Pediatric Nephrology at Floating Hospital
for Children in Boston offers a range of services
for kids with kidney
disease, including renal biopsies,
acute and chronic dialysis, 24 - hour blood pressure monitoring, hemofiltration and renal transplantation.
For loss of appetite is a typical manifestation of any
acute disease and many chronic ones.
The Preventing Overprescribing
for Pain Act would require the Centers
for Disease Control and Prevention (CDC) to issue guidelines
for the safe prescribing of opioids
for the treatment of
acute pain.
The Centers
for Disease Control and Prevention should issue guidelines
for doctors on prescribing opioids to treat
acute pain, U.S. Sen. Kirsten Gillibrand said Thursday.
Senator Gillibrand's legislation would require the Centers
for Disease Control and Prevention (CDC) to issue guidelines
for the safe prescribing of opioids
for the treatment of
acute pain.
Exposure to secondhand smoking can cause a vast array of health and respiratory symptoms and issues in young children, according to the Center
for Disease Control and Prevention, including coughing, wheezing, breathlessness, and
acute lower respiratory infections.
The interplay between malnutrition and malaria is poorly understood, but the risk of death is certainly higher in children with
acute malnutrition, at least among those who make it to a hospital, says Larry Slutsker, who directed the malaria and parasitic
diseases program at the U.S. Centers
for Disease Control and Prevention (CDC) in Atlanta and now runs the malaria program at PATH in Seattle, Washington.
Scientists study VSV, which causes
acute disease in livestock but typically does not lead to illness in people, as a model
for viruses that are harmful to humans.
«Meta studies have shown that the controlled grafting of fecal transplantation from healthy donors is a safe and very effective treatment of
acute diarrheal
diseases caused by the pathogenic bacterium Clostridium difficile,» said Sieglinde Angelberger, gastroenterologist at the University Clinic
for Internal Medicine III of the Medical University of Vienna and author of the study: «this was the reason why we applied this therapy
for the treatment of patients with chronic intestinal
diseases.»
«Considering that no prior research has conclusively demonstrated benefit of corticosteroid therapy
for any manifestation of Lyme
disease, including neurologic, rheumatologic or cardiac manifestations, we urge strong caution in prescribing corticosteroids in cases where facial paralysis is clearly the result of
acute Lyme
disease until better evidence is available,» said Dr. Jowett.
In their study, Fiona Havers, MD, MHS, and a team from the Centers
for Disease Control and Prevention and several other institutions analyzed data
for approximately 6,800 patients with
acute respiratory illness who were seen at five outpatient care centers in Washington state, Wisconsin, Texas, Michigan, and Pennsylvania.
The monkeys were treated early in the
acute phase of their
disease, soon after they were infected, whereas people in the studies had all been infected
for many months or even years.
International guidelines published in 2013 stated that a short course of oral corticosteroids may be helpful to reduce
disease duration
for acute hives.
SPADE will work best with
acute and subacute
diseases for which a misdiagnosis that leads to hospitalization, disability or death is likely to occur within six months to a year.
«Strengthened infection control practices and having a powerful active surveillance program
for acute respiratory illnesses are key to the rapid and prompt response
for emerging respiratory infections,» cautions lead author I.S. Al - Abaidani, MD, Department of Communicable
Disease, Ministry of Health, Oman.
Study findings indicate that among older adults who had diabetes
for a shorter duration (9 years or less), nonfatal cardiovascular complications had the highest incidence (coronary artery
disease, congestive heart failure, and cerebrovascular
disease), followed by diabetic eye
disease and
acute hypoglycemic events.
Tuberculosis reached epidemic proportions, and infant mortality rates quadrupled, with
acute respiratory
diseases accounting
for 50 percent of the deaths.
To find out if complications of pregnancy might be associated with the risk of early coronary heart
disease, the researchers compared 153 patients with
acute coronary syndrome, which includes heart attack and angina, with the same number of healthy people matched
for age and sex.
«Detecting genetic associations in cases of
acute viral bronchiolitis is the first step toward the development of tests to predict the possible clinical outcome
for each patient diagnosed with the
disease soon after arrival at the emergency room,» said Fernando Augusto de Lima Marson, a researcher at FCM - UNICAMP and one of the authors of the article.
While death rates from the
acute phase of cardiovascular events have decreased, the
disease burden remains high in the increasing number of survivors, which is especially important
for those affected at a young age.
In the U.S. nearly 3,000
acute cases of HBV were reported to the Centers
for Disease Control and Prevention (CDC) in 2012.
Yesterday, director Li Liming of the Center
for Disease Control and Prevention (CDC) resigned, along with several lower - ranking officials, after a report by a panel of experts blamed China's most recent outbreak of severe
acute respiratory syndrome on a series of flaws at the CDC's National Institute of Virology in southern Beijing.
A patent application
for a drug that could destroy the deadly childhood
disease known as
acute lymphoblastic leukemia — and potentially other cancers as well — has been submitted by researchers at Sandia National Laboratories, the University of Maryland and the MD Anderson Cancer Center in Houston.
Laboratory safety emerged as a prominent issue in China in 2004, when a series of missteps at China's Center
for Disease Control and Prevention led to a renewed outbreak of severe
acute respiratory sickness (SARS).
In a paper published in Annals of Internal Medicine, the American College of Physicians (ACP) and the Centers
for Disease Control and Prevention (CDC) issued advice
for prescribing antibiotics
for acute respiratory tract infections (ARTIs) in adults.
In 2002, the Centers
for Disease Control investigated several clusters of
acute lymphatic leukemia in both Nevada and Arizona.
Our results establish planarians as an experimentally tractable animal model
for research into the pathophysiology of
acute porphyrias, and potentially
for the identification of novel pharmacological interventions capable of alleviating porphyrin - mediated photosensitivity or decoupling dieting and fasting from
disease pathogenesis.
In 2003, DNA sequencing at the Michael Smith Genome Sciences Centre in Toronto and at the Centers
for Disease Control in Atlanta showed that the virus causing an outbreak of severe
acute respiratory syndrome (SARS) in China was a new variant of coronavirus.
In one trial involving 53 children with
acute lymphoblastic leukaemia — the
disease that Layla had —
for whom conventional therapies had not worked, 29 are still in remission months or years after treatment.
Legionella pneumophila (green), the bacterium responsible
for severe
acute lung
disease inside eukaryotic cells.
By understanding the role stem cells play in the repair of the nervous and cardiovascular systems, we are hoping to develop alternative therapies
for acute injury and chronic
diseases.
Endari, the first new treatment
for patients with sickle cell
disease in almost 20 years, Genentech's Hemlibra, the first - ever non-blood product to treat patients with hemophilia A with inhibitors, Actemra, the first treatment
for adults diagnosed with giant cell arteritis, BioMarin's Brineura, the first treatment
for a form of Batten
disease, Benznidazole, the first U.S. treatment
for Chagas
disease, Novartis» Kymriah to treat certain children and young adults with B - cell
acute lymphoblastic leukemia, which is also the first gene therapy to become available in the United States, are some of the drugs that received the FDA's stamp of approval in 2017.
Integrating genetic risk factors with minimal residual
disease (MRD) improves the accuracy of risk stratification
for children with
acute lymphoblastic leukemia (ALL), according to a population - based cohort study published in the Journal of Clinical Oncology.
«Our results show that, in an era in which high - resolution molecular typing
for class I and class II HLA [human leukocyte antigen] loci has significantly improved the clinical outcome of unrelated donor HSCT by decreasing the risk of immunological complications, lowering the ATLG dose to 15 mg / kg did not affect the time to engraftment and, more importantly, the incidence of
acute or chronic GVHD [graft - vs - host
disease], and was associated with an improved probability of event - free survival, mainly due to a reduced risk of nonrelapse mortality,» wrote Franco Locatelli, MD, of the department of oncoematologia pediatrica, IRCCS Ospedale «Bambino Gesù» in Rome, and colleagues.
The Laboratory
for Molecular Neuroscience investigates molecular mechanisms involved in the development of
acute and chronic neurodegenerative
disease, with a focus on the role of glutamate excitotoxicity.
In a Cox proportional hazards model adjusting
for age, examination years and all other predictive coronary
disease risk factors, blood donors had a 88 % reduced risk (relative hazard = 0.12, 95 % confidence interval 0.02 - 0.86, p = 0.035) of
acute myocardial infarction, compared with non-blood donors.
Although medical and surgical treatments available today
for the ischemic heart
disease patients diminish the risk of
acute myocardial infarction and reduce to some extent the incidence of recurrent heart attack, one of the unsolved challenges is to affect myocardium remodeling occurring during ischemic heart failure.